Simplex Trading
OBIO icon

Simplex Trading’s Orchestra BioMed OBIO Stock Holding History

Simplex Trading’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,300
Closed -$101K – 9837
2025
Q4 		$101K Buy
+24,300
New +$98K ﹤0.01% 4992

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Simplex Trading's OBIO Position: Q2 2026 in Review

Simplex Trading increased its Orchestra BioMed (OBIO) stake by 7.7% in Q2 2026, buying an estimated $748 and bringing the position to 2,564 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7608.

Simplex Trading first reported a position in OBIO in Q3 2025 and has held it in 3 quarters since. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Simplex Trading held 2,564 shares of Orchestra BioMed worth $11.1K as of Q2 2026.
  • Simplex Trading bought 183 Orchestra BioMed shares in Q2 2026, an estimated $748.
  • Orchestra BioMed made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7608 holding.
  • Simplex Trading first reported a position in Orchestra BioMed in Q3 2025 and has held it in 3 quarters since.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.